#AstraZeneca's rare disease unit #Alexion has claimed a positive opinion from the #EMA's human medicines committee for #generalisedmyastheniagravis (gMG) therapy #Klygefa.

pharmaphorum.com/news/azs-gmg...

Klygefa®: A New Hope for Adults with Generalized Myasthenia Gravis in Japan #Japan #Myasthenia_Gravis #Minato-ku,_Tokyo #Klygefa #Alexion_Pharma